#United States #Irvine #Danaher #Masimo #Tim Benner

Masimo Appoints Tim Benner as President

On August 4, 2026, Masimo, part of the Danaher Corporation, made a significant announcement: Tim Benner has been appointed as the new President, effective August 3, 2026. This decision underscores the company’s commitment to its mission of advancing healthcare through innovative diagnostic solutions, particularly in pulse oximetry and patient monitoring.

Tim Benner's journey with Masimo started in June 2025, during which he played a pivotal role in shaping the company’s strategic direction. His involvement in strengthening customer relationships and transitioning the company post-acquisition by Danaher has been instrumental. Before his current role, Benner held positions as Chief Marketing and Strategy Officer and served most recently as Chief Commercial Officer. In these capacities, he managed Masimo's global sales organization, marketing efforts, strategic growth initiatives, and customer engagement strategies. His promotion to President reflects the confidence both Masimo and Danaher leadership have in his ability to steer the company into its next phase of growth and innovation.

Julie Sawyer Montgomery, the designated CEO of Danaher Corporation, highlighted, "Tim is a strong and experienced leader at Masimo and has significantly contributed to positioning the company for long-term success. His strategic leadership, deep understanding of customers, and commitment to innovation make him the right leader for Masimo’s next chapter as part of the Danaher Group."

With more than three decades of experience in executive roles within the med-tech industry, Benner’s extensive background includes leadership positions at prominent organizations such as Edwards Lifesciences, Abbott, Terumo, and Inari Medical/Stryker. Throughout his career, he has fostered high-performing teams, driven commercial excellence, and made innovative healthcare technologies more accessible to physicians and patients globally.

In his own words, Benner expressed his enthusiasm for leading Masimo: "It is an honor to take on the role of President at Masimo. For over three decades, Masimo has earned the trust of healthcare professionals worldwide by developing groundbreaking technologies that enhance patient care. As part of the Danaher Corporation, we have a unique opportunity to build on this legacy by combining Masimo’s spirit of innovation with the capabilities of the Danaher Business System. I look forward to continuing to deliver impactful innovations alongside our talented employees and customers to improve treatment outcomes for patients worldwide."

As President, Benner will oversee Masimo’s global operations, driving innovation across the company's patient monitoring portfolio, enhancing partnerships with customers, accelerating business growth, and advancing Masimo’s mission to improve patient outcomes through pioneering technologies.

About Masimo

Masimo, as part of the Danaher Group, is renowned for its innovative diagnostic solutions in pulse oximetry and various patient monitoring applications. The company develops and manufactures a wide array of industry-leading monitoring technologies, including innovative measurement methods, sensors, patient monitors, and automation and connectivity solutions. Masimo's mission focuses on empowering medical professionals to improve patient care through its innovations.

The company’s flagship product, the Masimo SET®, introduced in 1995, revolutionized pulse oximetry by establishing itself as superior to other technologies through over 100 independent studies. Approximately 200 million patients globally are estimated to benefit from the Masimo SET® each year, making it the preferred pulse oximetry system in the top ten U.S. hospitals listed in Newsweek's "World's Best Hospitals" for 2026. For more information about Masimo and its products, visit masimo.com.

About Danaher

Danaher Corporation stands as a leading global innovator in Life Sciences and Diagnostics, dedicated to leveraging science and technology to enhance human health. Through a connected ecosystem of industry-leading companies, Danaher collaborates closely with customers to tackle complex scientific and clinical challenges, expediting the delivery of innovations from discovery to patient care. Supported by the Danaher Business System, the company’s advanced science and technology enable faster and more accurate diagnoses, while aiming to reduce the time and cost associated with researching, developing, and delivering transformative therapies. With over 60,000 employees globally, Danaher focuses on driving sustainable impacts and improving quality of life while fostering a healthier, more sustainable future. To learn more, visit danaher.com.